About this term
- Quick definition
- Slowing of movement, speech, and thought that is noticeable to others. The opposite, psychomotor agitation, involves restlessness or pacing.
- Full clinical definition
- Psychomotor change is one of the nine diagnostic criteria for a major depressive episode in the DSM-5-TR, listed as criterion A5. To meet the criterion, the change must be observable by others, not just reported by the patient. It can take the form of psychomotor retardation (slowing of movement, speech, and thought) or psychomotor agitation (restlessness, pacing, hand-wringing). Slowing is more commonly seen in melancholic and severe depressive episodes, including depression in older adults. The term "psychomotor" is intentional: the change cuts across the motor system and the cognitive system, and the two are usually impaired in parallel. A patient with significant psychomotor slowing typically shows both delayed responses to questions and a reduced rate of spontaneous movement, often with reduced facial expression and a flattened vocal range.
- Epidemiology
- Observable psychomotor change is reported in roughly 25 to 50 percent of inpatients with major depressive disorder and is a defining feature of the melancholic specifier. Across all severity levels of major depressive disorder, including outpatient and inpatient samples, the rate of clinically observable psychomotor slowing is in the range of 40 to 60 percent (Sobin and Sackeim, Am J Psychiatry, 1997). Rates are higher in melancholic depression, psychotic depression, depression in older adults, and depression presenting in the inpatient setting. In milder outpatient episodes, the symptom is often subtle and may go unrecognized unless the clinician specifically looks for it or asks a family member.
- What it can feel like
- Patients describe it in several overlapping ways. Slowed thought is often the first thing they notice: a sense that ideas form late, that words have to be searched for, that decisions take longer than they used to. Slowed movement shows up as a feeling of effort to do simple things, of walking through a heavier medium, of the body not responding the way the mind asks. Slowed speech is described as having to push the words out, long pauses before answering, sentences that trail off. Family members often see it before the patient does, and describe the person as if "wading through water" or "moving in slow motion." In severe cases, the person may sit motionless for long periods, or speak only in short, quiet phrases.
- Why it matters
- Psychomotor change is one of the diagnostic features of a major depressive episode and is a clue to severity. Marked psychomotor slowing is part of the melancholic specifier and is associated with greater short-term response to electroconvulsive therapy in severe depression. Severe slowing also raises the risk of dehydration, malnutrition, and missed medical care, and may require a higher level of clinical attention. Beyond its diagnostic role, the presence and severity of psychomotor slowing also influences prognosis and treatment selection. In studies of inpatient depression, marked psychomotor slowing predicts a longer mean episode duration when treated with antidepressants alone, a higher likelihood of needing combination or augmentation strategies, and, in the most severe cases, a higher likelihood that ECT will be chosen earlier in the sequence. In older adults, severe psychomotor slowing is a warning sign for pseudodementia, where depression mimics cognitive decline and improves with treatment of the underlying mood disorder.
- Differential considerations
- Apparent psychomotor slowing in a depressed patient is not always primary to the mood disorder. Hypothyroidism, untreated obstructive sleep apnea, Parkinson disease, normal-pressure hydrocephalus, vascular cognitive impairment, sedating medications (including benzodiazepines, opioids, antihistamines, and some antipsychotics), recent stroke, and substance use can all mimic or amplify psychomotor slowing. In older adults, depression with marked psychomotor slowing and cognitive complaints is sometimes called pseudodementia and can be difficult to separate from early neurodegenerative disease without treatment of the mood episode and reassessment. A clinician therefore reviews the medication list, basic labs, and neurological exam alongside the psychiatric assessment when slowing is prominent.
- Course and prognosis
- When psychomotor slowing is part of a treated depressive episode, it usually improves alongside the rest of the syndrome, often within the first three to six weeks of an adequate antidepressant trial. The order of improvement is not always uniform: many patients notice that their pace of speech and movement returns toward baseline before their subjective mood does, and family members frequently report the change before the patient does. Persistent psychomotor slowing after mood has otherwise improved is one of the more reliable signs that the episode is not in full remission and is a reason to revisit the treatment plan rather than to declare the trial complete. In the small subset of patients with recurrent severe melancholic depression, psychomotor slowing tends to recur in similar form across episodes, which can be useful to recognize when planning maintenance treatment.
- Practical examples
- A 62-year-old man with recurrent major depressive disorder presents to clinic, sits with a flat facial expression, and answers questions with a delay of three to five seconds. His wife reports that he has stopped initiating conversation at home and takes nearly an hour to dress in the morning. This pattern meets criterion A5 on the basis of observable change. A 28-year-old woman with a first episode of major depressive disorder reports feeling "slowed down" and says her thoughts feel sluggish, but her clinic interview is brisk, her speech rate is normal, and her family has noticed no change. She does not meet criterion A5 on the basis of observable change, although her subjective experience is still clinically significant and contributes to other criteria such as fatigue and concentration difficulty.
- How clinicians assess it
- A key feature of the DSM-5-TR criterion (criterion A5) is that the change must be observable by others, not just self-reported by the patient. A patient who reports feeling slowed down without any visible change in speech, movement, or reaction time does not meet the criterion for criterion A5 on its own, though the report is still clinically meaningful. The clinician therefore observes the patient's pace of speech and movement during the visit, watches for long latencies between question and answer, notes whether the patient initiates movement spontaneously, and asks family members about changes at home. The CORE Assessment of Psychomotor Change is a structured tool used in some research and specialty settings. The PHQ-9 captures the symptom indirectly through items on energy and concentration but does not separately measure observable slowing.
- Treatment implications
- Treatment of the underlying depression is the main path. Severe psychomotor slowing, especially with poor oral intake or catatonia, can be a reason to consider hospitalization, electroconvulsive therapy, or both. Severe psychomotor slowing is in fact one of the strongest clinical predictors of response to electroconvulsive therapy in major depressive disorder (Petrides et al., J ECT, 2001), and most ECT consensus guidance treats marked psychomotor change, melancholic features, and psychotic features as indications where ECT is considered earlier rather than later in the treatment sequence, rather than reserved as a last resort. Improvement in psychomotor symptoms is often one of the earlier signs of response to treatment, sometimes preceding subjective mood improvement by days to weeks. Among antidepressants, agents with noradrenergic or dopaminergic activity (such as bupropion and the serotonin-norepinephrine reuptake inhibitors) are often favored when slowing is prominent, though the supporting evidence is weaker than for the role of ECT in severe cases. Adjunctive psychostimulants are sometimes used in older adults with marked retardation and medical comorbidity, where a fuller antidepressant trial would take too long.
- What it is not
- Psychomotor slowing is not the same as fatigue, although the two often coexist. Fatigue describes a subjective sense of low energy, while psychomotor slowing describes observable changes in the pace of movement, speech, and thought. A patient can have one without the other, and the distinction matters because the treatment emphasis and prognosis are not identical. Psychomotor slowing is also not the same as sedation from medication, which usually improves with dose adjustment or a change of agent, and is not the same as the bradykinesia of Parkinson disease, which has its own neurological signature on examination.
- Related terms
- Major depressive disorder. Fatigue. Depressed mood.
- Related articles
- Fatigue and depression. Treatment.
Sources
- American Psychiatric Association. DSM-5-TR.
- Sobin C, Sackeim HA. Psychomotor symptoms of depression. Am J Psychiatry. 1997.
- Schrijvers D, Hulstijn W, Sabbe BG. Psychomotor symptoms in depression: a diagnostic, pathophysiological and therapeutic tool. J Affect Disord. 2008.
- Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001.